{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:04:50Z","timestamp":1784909090695,"version":"3.55.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ymgmr.2026.101308","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T17:06:42Z","timestamp":1775495202000},"page":"101308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Adult disease burden in patients with mucopolysaccharidosis type I H (Hurler syndrome): A comprehensive literature review with patient case analysis"],"prefix":"10.1016","volume":"47","author":[{"given":"Emma N.","family":"Lusk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Percival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caylee A.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Prohofsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie M.","family":"Minett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan L.","family":"Snow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl_5","key":"10.1016\/j.ymgmr.2026.101308_bb0005","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101308_bb0010","first-page":"1","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"8","key":"10.1016\/j.ymgmr.2026.101308_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081838","article-title":"Mucopolysaccharidosis type I: a review of the natural history and molecular pathology","volume":"9","author":"Hampe","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.ymgmr.2026.101308_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041258","article-title":"Mucopolysaccharidosis type II: one hundred years of research, diagnosis, and treatment","volume":"21","author":"D\u2019Avanzo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ymgmr.2026.101308_bb0025","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1515\/jpem-2020-0742","article-title":"Global epidemiology of mucopolysaccharidosis type III (sanfilippo syndrome): an updated systematic review and meta-analysis","volume":"34","author":"Kong","year":"2021","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ymgmr.2026.101308_bb0030","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00247-022-05585-3","article-title":"A pictorial review of the radiographic skeletal findings in morquio syndrome (mucopolysaccharidosis type IV)","volume":"53","author":"Padash","year":"2023","journal-title":"Pediatr. Radiol."},{"issue":"24","key":"10.1016\/j.ymgmr.2026.101308_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413456","article-title":"Mucopolysaccharidosis type VI, an updated overview of the disease","volume":"22","author":"D\u2019Avanzo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgmr.2026.101308_bb0040","series-title":"Screening Mucopolysaccharidosis Type IX in Patients with Juvenile Idiopathic Arthritis","first-page":"21","author":"Kiykim","year":"2015"},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101308_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MCD.0000000000000149","article-title":"A probable new syndrome with the storage disease phenotype caused by the VPS33A gene mutation","volume":"26","author":"Dursun","year":"2017","journal-title":"Clin. Dysmorphol."},{"issue":"10","key":"10.1016\/j.ymgmr.2026.101308_bb0050","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/jmedgenet-2021-108061","article-title":"Novel subtype of mucopolysaccharidosis caused by arylsulfatase k (ARSK) deficiency","volume":"59","author":"Verheyen","year":"2022","journal-title":"J. Med. Genet."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgmr.2026.101308_bb0055","first-page":"102","article-title":"Mucopolysaccharidosis type i","volume":"12","author":"Wraith","year":"2014","journal-title":"Pediatr. Endocrinol. Rev."},{"issue":"10","key":"10.1016\/j.ymgmr.2026.101308_bb0060","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/gim.2014.25","article-title":"The natural history of MPS i: global perspectives from the MPS i registry","volume":"16","author":"Beck","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgmr.2026.101308_bb0065","unstructured":"R. Sakuru and P. C. Bollu, \u201cHurler syndrome,\u201d StatPearls [Internet], 2023, Accessed: Sep. 05, 2025. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532261\/."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101308_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-021-01880-8","article-title":"Epidemiology of mucopolysaccharidoses (MPS) in United States: challenges and opportunities","volume":"16","author":"Puckett","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101308_bb0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1172-3-24","article-title":"The prevalence of and survival in mucopolysaccharidosis i: Hurler, Hurler-Scheie and scheie syndromes in the UK","volume":"3","author":"Moore","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2026.101308_bb0080","series-title":"Mucopolysaccharidosis Type I","author":"Clarke","year":"2024"},{"issue":"2","key":"10.1016\/j.ymgmr.2026.101308_bb0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10545-012-9533-7","article-title":"Molecular characterization of 355 mucopolysaccharidosis patients reveals 104 novel mutations","volume":"36","author":"Pollard","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgmr.2026.101308_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2025.109131","article-title":"Combining clinically benign IDUA variants in cis reduces enzymatic activity of the resulting enzyme within the pathogenic range","volume":"145","author":"Yu","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2026.101308_bb0095","first-page":"116","article-title":"A rare disease in two brothers","volume":"10","author":"Hunter","year":"1917","journal-title":"Proc. R. Soc. Med."},{"issue":"5\u20136","key":"10.1016\/j.ymgmr.2026.101308_bb0100","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF02222956","article-title":"\u00dcber einen typ multipler abartungen, vorwiegend am skelettsystem","volume":"24","author":"Hurler","year":"1920","journal-title":"Z. Kinderheilkd."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101308_bb0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/oxfordjournals.qjmed.a067991","article-title":"Gargoylism (Chondro-osteo-dystrophy, corneal opacities, hepatosplenomegaly, and mental deficiency)","volume":"5","author":"Ellis","year":"1936","journal-title":"QJM: Intern. J. Med."},{"issue":"2","key":"10.1016\/j.ymgmr.2026.101308_bb0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajmg.c.31903","article-title":"Rejecting Gargoylism: reflections on the term and its relationship to hurler syndrome","volume":"187","author":"Abbott","year":"2021","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101308_bb0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/00365515209060631","article-title":"Gargoylism - a mucopolysaccharidosis","volume":"4","author":"Brante","year":"1952","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"5","key":"10.1016\/j.ymgmr.2026.101308_bb0120","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0002-9394(62)93395-0","article-title":"A newly recognized forme fruste of hurlers disease (gargoylism)","volume":"53","author":"Scheie","year":"1962","journal-title":"Am. J. Ophthalmol."},{"issue":"3853","key":"10.1016\/j.ymgmr.2026.101308_bb0125","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.162.3853.570","article-title":"Hurler and hunter syndromes: mutual correction of the defect in cultured fibroblasts","volume":"162","author":"Fratantoni","year":"1968","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ymgmr.2026.101308_bb0130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3928\/00904481-19780201-06","article-title":"The mucopolysaccharidoses: advances in understanding and treatment","volume":"7","author":"Lorincz","year":"1978","journal-title":"Pediatr. Ann."},{"issue":"8","key":"10.1016\/j.ymgmr.2026.101308_bb0135","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1073\/pnas.69.8.2048","article-title":"The defect in the hurler and scheie syndromes: deficiency of \u03b1-L-Iduronidase","volume":"69","author":"Bach","year":"1972","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"21","key":"10.1016\/j.ymgmr.2026.101308_bb0140","doi-asserted-by":"crossref","first-page":"9695","DOI":"10.1073\/pnas.88.21.9695","article-title":"Human alpha-L-iduronidase: CDNA isolation and expression","volume":"88","author":"Scott","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.ymgmr.2026.101308_bb0145","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbmt.2008.01.009","article-title":"The clinical outcome of hurler syndrome after stem cell transplantation","volume":"14","author":"Aldenhoven","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"6","key":"10.1016\/j.ymgmr.2026.101308_bb0150","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00431-011-1644-x","article-title":"Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS i registry","volume":"171","author":"D\u2019Aco","year":"2012","journal-title":"Eur. J. Pediatr."},{"issue":"79","key":"10.1016\/j.ymgmr.2026.101308_bb0155","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/adc.14.79.217","article-title":"Dysostosis multiplex: Pfaundler-Hurler syndrome report of two cases","volume":"14","author":"Engel","year":"1939","journal-title":"Arch. Dis. Child."},{"issue":"3","key":"10.1016\/j.ymgmr.2026.101308_bb0160","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10545-011-9304-x","article-title":"Orthopaedic management of hurlers disease after hematopoietic stem cell transplantation: a systematic review","volume":"34","author":"Van Der Linden","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ymgmr.2026.101308_bb0165","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3171\/2024.1.PEDS23281","article-title":"Natural history of craniovertebral abnormalities in a single-center study in 54 patients with hurler syndrome","volume":"33","author":"Huang","year":"2024","journal-title":"J. Neurosurg. Pediatr."},{"issue":"19","key":"10.1016\/j.ymgmr.2026.101308_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911168","article-title":"MPSI manifestations and treatment outcome: skeletal focus","volume":"23","author":"De Ponti","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ymgmr.2026.101308_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020189","article-title":"Mucopolysaccharidosis type I: current treatments, limitations, and prospects for improvement","volume":"11","author":"Hampe","year":"2021","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.ymgmr.2026.101308_bb0180","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/ana.26786","article-title":"Hurler syndrome glycosaminoglycans decrease in cerebrospinal fluid without brain-targeted therapy","volume":"94","author":"Lund","year":"2023","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.ymgmr.2026.101308_bb0185","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jimd.12598","article-title":"Persistent bone and joint disease despite current treatments for mucopolysaccharidosis types i, II, and VI: data from a 10-year prospective study","volume":"46","author":"Miller","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgmr.2026.101308_bb0190","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-263X.2010.01055.x","article-title":"Oral features and dental health in hurler syndrome following hematopoietic stem cell transplantation","volume":"20","author":"McGovern","year":"2010","journal-title":"Int. J. Paediatr. Dent."},{"issue":"6","key":"10.1016\/j.ymgmr.2026.101308_bb0195","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/17446651.2022.2144229","article-title":"Facial features of lysosomal storage disorders","volume":"17","author":"D\u2019Souza","year":"2022","journal-title":"Expert. Rev. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ymgmr.2026.101308_bb0200","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00784-017-2240-x","article-title":"Differences in maxillomandibular morphology among patients with mucopolysaccharidoses i, II, III, IV and VI: a retrospective MRI study","volume":"22","author":"Koehne","year":"2018","journal-title":"Clin. Oral Investig."},{"issue":"4","key":"10.1016\/j.ymgmr.2026.101308_bb0205","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11325-019-01900-9","article-title":"Obstructive sleep apnea and craniofacial appearance in MPS type I-Hurler children after hematopoietic stem cell transplantation","volume":"23","author":"Koehne","year":"2019","journal-title":"Sleep Breath."},{"issue":"3","key":"10.1016\/j.ymgmr.2026.101308_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10030161","article-title":"Mucopolysaccharidosis type I","volume":"10","author":"Kubaski","year":"2020","journal-title":"Diagnostics"},{"issue":"2","key":"10.1016\/j.ymgmr.2026.101308_bb0215","first-page":"47","article-title":"Anesthesiological risks in mucopolysaccharidoses","volume":"44","author":"Moretto","year":"2018","journal-title":"Ital. J. Pediatr."},{"issue":"3","key":"10.1016\/j.ymgmr.2026.101308_bb0220","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1399-6576.1987.tb02553.x","article-title":"Mucopolysaccharidoses and anaesthetic risks","volume":"31","author":"Sj\u00f8gren","year":"1987","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"January\u2013December","key":"10.1016\/j.ymgmr.2026.101308_bb0225","first-page":"1","article-title":"Obstructive sleep apnea in MPS: a systematic review of pretreatment and posttreatment prevalence and severity","volume":"2015","author":"Pal","year":"2015","journal-title":"J. Inborn Errors Metab. Screen."},{"issue":"6","key":"10.1016\/j.ymgmr.2026.101308_bb0230","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.bbmt.2018.01.028","article-title":"Metabolic syndrome and cardiovascular risk factors after hematopoietic cell transplantation in severe mucopolysaccharidosis type i (Hurler syndrome)","volume":"24","author":"Braunlin","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.ymgmr.2026.101308_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2025.109687","article-title":"Vascular complications and imaging-based cardiovascular risk assessment in mucopolysaccharidoses: a systematic review","volume":"147","author":"McCarron","year":"2026","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101308_bb0240","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/01.CIR.31.1.132","article-title":"Cardiovascular manifestations of the hurler syndrome: hemodynamic and angiocardiographic observations in 15 patients","volume":"31","author":"Krovetz","year":"1965","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ymgmr.2026.101308_bb0245","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10545-017-0034-6","article-title":"Long term survival and cardiopulmonary outcome in children with hurler syndrome after haematopoietic stem cell transplantation","volume":"40","author":"Lum","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgmr.2026.101308_bb0250","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ymgme.2018.08.003","article-title":"Anatomical changes and pathophysiology of the brain in mucopolysaccharidosis disorders","volume":"125","author":"Bigger","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101308_bb0255","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3174\/ajnr.A2832","article-title":"Brain and spinal MR imaging findings in mucopolysaccharidoses: a review","volume":"34","author":"Zafeiriou","year":"2013","journal-title":"Am. J. Neuroradiol."},{"issue":"2","key":"10.1016\/j.ymgmr.2026.101308_bb0260","first-page":"107","article-title":"Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses","volume":"44","author":"Barone","year":"2018","journal-title":"Ital. J. Pediatr."},{"issue":"3","key":"10.1016\/j.ymgmr.2026.101308_bb0265","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bjorl.2015.05.007","article-title":"Audiologic evaluations of children with mucopolysaccharidosis","volume":"82","author":"G\u00f6kdo\u011fan","year":"2015","journal-title":"Braz. J. Otorhinolaryngol."},{"issue":"8","key":"10.1016\/j.ymgmr.2026.101308_bb0270","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/ICO.0000000000003214","article-title":"Changes in corneal clouding over time in patients with mucopolysaccharidosis","volume":"42","author":"McGrath","year":"2023","journal-title":"Cornea"},{"key":"10.1016\/j.ymgmr.2026.101308_bb0275","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ajo.2021.05.014","article-title":"Mucopolysaccharidosis type I\u2013associated corneal disease: a clinicopathologic study","volume":"231","author":"Williams","year":"2021","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymgmr.2026.101308_bb0280","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.exer.2016.05.022","article-title":"A novel explanation of corneal clouding in a bone marrow transplant-treated patient with hurler syndrome","volume":"148","author":"Yuan","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymgmr.2026.101308_bb0285","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s13023-020-01598-z","article-title":"Survival and diagnostic age of 175 taiwanese patients with mucopolysaccharidoses (1985\u20132019)","volume":"15","author":"Lin","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101308_bb0290","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-0028-1095171","article-title":"Thin layer chromatography of urinary acid glycosaminoglycans as screening procedure for mucopolysaccharidoses","volume":"1","author":"Teller","year":"1969","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ymgmr.2026.101308_bb0295","first-page":"123","article-title":"Dried blood spots allow targeted screening to diagnose mucopolysaccharidosis and mucolipidosis","volume":"15","author":"Cobos","year":"2014","journal-title":"JIMD Rep."},{"issue":"2","key":"10.1016\/j.ymgmr.2026.101308_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108612","article-title":"High precision newborn screening for mucopolysaccharidosis type i by enzymatic activity followed by endogenous, non-reducing end glycosaminoglycan analysis","volume":"144","author":"Herbst","year":"2025","journal-title":"Mol. Genet. Metab."},{"issue":"8249","key":"10.1016\/j.ymgmr.2026.101308_bb0305","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(81)91046-1","article-title":"Reversal of clinical features of hurlers disease and biochemical improvement after treatment by bone-marrow transplantation","volume":"318","author":"Hobbs","year":"1981","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.ymgmr.2026.101308_bb0310","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1056\/NEJMoa032613","article-title":"Cord-blood transplants from unrelated donors in patients with hurlers syndrome","volume":"350","author":"Staba","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ymgmr.2026.101308_bb0315","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2522\/ptj.20070017","article-title":"Gross motor development of children with hurler syndrome after umbilical cord blood transplantation","volume":"87","author":"Dusing","year":"2007","journal-title":"Phys. Ther."},{"issue":"7","key":"10.1016\/j.ymgmr.2026.101308_bb0320","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.bmt.1701407","article-title":"Meningioma in long-term survivors after allogeneic bone marrow transplantation","volume":"22","author":"Meignin","year":"1998","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.ymgmr.2026.101308_bb0325","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF00710052","article-title":"The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and hurler syndrome","volume":"18","author":"Krivit","year":"1995","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101308_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-020-01644-w","article-title":"Long term disease burden post-transplantation: three decades of observations in 25 hurler patients successfully treated with hematopoietic stem cell transplantation (HSCT)","volume":"16","author":"Guffon","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"10.1016\/j.ymgmr.2026.101308_bb0335","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/jnnp.2007.133892","article-title":"Bilateral idiopathic hypertrophy of the first dorsal interosseous muscles in a 43-year-old man","volume":"79","author":"Boelmans","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"19","key":"10.1016\/j.ymgmr.2026.101308_bb0340","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1182\/blood-2012-09-455238","article-title":"Outcomes of transplantation using various hematopoietic cell sources in children with hurler syndrome after myeloablative conditioning","volume":"121","author":"Boelens","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ymgmr.2026.101308_bb0345","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/j.bbmt.2019.02.012","article-title":"Hematopoietic stem cell transplantation for mucopolysaccharidoses: past, present, and future","volume":"25","author":"Taylor","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101308_bb0350","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3847","article-title":"Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis i","volume":"123","author":"Clarke","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101308_bb0355","doi-asserted-by":"crossref","DOI":"10.1186\/s12881-016-0284-4","article-title":"12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis i: the important role of early treatment","volume":"17","author":"Gabrielli","year":"2016","journal-title":"BMC Med. Genet."},{"issue":"11","key":"10.1016\/j.ymgmr.2026.101308_bb0360","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/gim.2018.29","article-title":"Long-term outcomes of systemic therapies for hurler syndrome: an international multicenter comparison","volume":"20","author":"Eisengart","year":"2018","journal-title":"Genet. Med."},{"issue":"20","key":"10.1016\/j.ymgmr.2026.101308_bb0365","article-title":"A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for fabrys disease and mucopolysaccharidosis type 1","volume":"10","author":"Connock","year":"2006","journal-title":"Health Technol. Assess. (Rockv.)."},{"key":"10.1016\/j.ymgmr.2026.101308_bb0370","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.wneu.2020.04.055","article-title":"Treatment of severe kyphoscoliosis in children with mucopolysaccharidosis type i (Pfaundler\u2013Hurler syndrome) using the growing rod technique: a case series with mid-term results","volume":"139","author":"Hofmann","year":"2020","journal-title":"World Neurosurg."},{"issue":"11","key":"10.1016\/j.ymgmr.2026.101308_bb0375","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1469-8749.2006.02027a.x","article-title":"Gross motor abilities in children with hurler syndrome","volume":"48","author":"Dusing","year":"2006","journal-title":"Dev. Med. Child Neurol."},{"issue":"12","key":"10.1016\/j.ymgmr.2026.101308_bb0380","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/bloodadvances.2020001708","article-title":"Hurdles in treating hurler disease: potential routes to achieve a \u2018real\u2019 cure","volume":"4","author":"Van Den Broek","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymgmr.2026.101308_bb0385","first-page":"75","article-title":"Pilot study of the safety and effect of adalimumab on pain, physical function, and musculoskeletal disease in mucopolysaccharidosis types i and II","volume":"10","author":"Polgreen","year":"2017","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2026.101308_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.863667","article-title":"The inflammation in the cytopathology of patients with mucopolysaccharidoses- immunomodulatory drugs as an approach to therapy","volume":"13","author":"Wiesinger","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymgmr.2026.101308_bb0395","article-title":"Evaluation of etanercept (a tumor necrosis factor alpha inhibitor) as an effective treatment for joint disease in mucopolysaccharidosis type i. a case report with whole-body magnetic resonance imaging","volume":"10","author":"Buchinskaya","year":"2024","journal-title":"Front. Med. (Lausanne)."},{"issue":"11","key":"10.1016\/j.ymgmr.2026.101308_bb0400","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/s41436-019-0522-1","article-title":"Intrathecal enzyme replacement for hurler syndrome: biomarker association with neurocognitive outcomes","volume":"21","author":"Eisengart","year":"2019","journal-title":"Genet. Med."},{"issue":"12","key":"10.1016\/j.ymgmr.2026.101308_bb0405","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1080\/17425247.2016.1202235","article-title":"Nanotechnology applied to treatment of mucopolysaccharidoses","volume":"13","author":"Schuh","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"issue":"4","key":"10.1016\/j.ymgmr.2026.101308_bb0410","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1021\/acs.molpharmaceut.6b01166","article-title":"Brain and organ uptake in the rhesus monkey in vivo of recombinant iduronidase compared to an insulin receptor antibody\u2013iduronidase fusion protein","volume":"14","author":"Boado","year":"2017","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.ymgmr.2026.101308_bb0415","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ymthe.2024.01.009","article-title":"\u0391-L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type i: a phase 1\/2 trial","volume":"32","author":"Harmatz","year":"2024","journal-title":"Mol. Ther."},{"issue":"1\u20132","key":"10.1016\/j.ymgmr.2026.101308_bb0420","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41434-019-0113-4","article-title":"Neonatal nonviral gene editing with the CRISPR\/Cas9 system improves some cardiovascular, respiratory, and bone disease features of the mucopolysaccharidosis i phenotype in mice","volume":"27","author":"Schuh","year":"2020","journal-title":"Gene Ther."},{"issue":"11","key":"10.1016\/j.ymgmr.2026.101308_bb0425","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1016\/j.ymthe.2024.09.033","article-title":"Engineering memory t cells as a platform for long-term enzyme replacement therapy in lysosomal storage disorders","volume":"32","author":"Kleinboehl","year":"2024","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101308_bb0430","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/diseases5010005","article-title":"Substrate deprivation therapy to reduce glycosaminoglycan synthesis improves aspects of neurological and skeletal pathology in MPS i mice","volume":"5","author":"Derrick-Roberts","year":"2017","journal-title":"Diseases"},{"issue":"5","key":"10.1016\/j.ymgmr.2026.101308_bb0435","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/FOC\/2008\/24\/5\/E7","article-title":"Radiation-induced meningioma","volume":"24","author":"Umansky","year":"2008","journal-title":"Neurosurg. Focus"},{"issue":"10","key":"10.1016\/j.ymgmr.2026.101308_bb0440","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/neuonc\/noae082","article-title":"Meningioma: international consortium on meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients","volume":"26","author":"Wang","year":"2024","journal-title":"Neuro-Oncology"},{"issue":"2","key":"10.1016\/j.ymgmr.2026.101308_bb0445","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.critrevonc.2008.01.010","article-title":"Meningioma","volume":"67","author":"Marosi","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"9","key":"10.1016\/j.ymgmr.2026.101308_bb0450","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3324\/haematol.2011.058644","article-title":"Hematopoietic stem cell transplantation improves the high incidence of neutralizing Allo-antibodies observed in hurlers syndrome after pharmacological enzyme replacement therapy","volume":"97","author":"Saif","year":"2012","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101308_bb0455","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jpeds.2008.07.004","article-title":"Use of enzyme replacement therapy (laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis i: experience in 18 patients","volume":"154","author":"Wynn","year":"2009","journal-title":"J. Pediatr."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgmr.2026.101308_bb0460","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13052-018-0552-3","article-title":"Newborn screening in mucopolysaccharidoses","volume":"44","author":"Donati","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.ymgmr.2026.101308_bb0465","series-title":"Functional and Clinical Neuroanatomy","first-page":"95","article-title":"Meninges and ventricles","author":"Moini","year":"2020"},{"issue":"12","key":"10.1016\/j.ymgmr.2026.101308_bb0470","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/S0025-6196(12)62193-4","article-title":"Intractable partial epilepsy: evaluation and treatment","volume":"65","author":"Cascino","year":"1990","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ymgmr.2026.101308_bb0475","series-title":"StatPearls [Internet]","article-title":"Partial Epilepsy","author":"Patel","year":"2023"},{"issue":"12","key":"10.1016\/j.ymgmr.2026.101308_bb0480","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1038\/s41436-019-0588-9","article-title":"Oncogenic effects of germline variants in lysosomal storage disease genes","volume":"21","author":"Shin","year":"2019","journal-title":"Genet. Med."},{"issue":"19","key":"10.1016\/j.ymgmr.2026.101308_bb0485","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3390\/cells13191664","article-title":"Oncological aspects of lysosomal storage diseases","volume":"13","author":"\u0141ugowska","year":"2024","journal-title":"Cells"},{"issue":"19","key":"10.1016\/j.ymgmr.2026.101308_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38652","article-title":"Intracranial tumor in a patient with mucopolysaccharidosis type 1 (scheie syndrome): an extremely rare combination","volume":"10","author":"Kukreja","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ymgmr.2026.101308_bb0495","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ymgme.2017.10.006","article-title":"Epilepsy in mucopolysaccharidosis disorders","volume":"122","author":"Scarpa","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101308_bb0500","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0920-1211(99)00066-2","article-title":"Intracranial meningiomas and epilepsy: incidence, prognosis and influencing factors","volume":"38","author":"Lieu","year":"1999","journal-title":"Epilepsy Res."},{"issue":"2","key":"10.1016\/j.ymgmr.2026.101308_bb0505","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymgme.2020.07.004","article-title":"The evolution of pulmonary function in childhood onset mucopolysaccharidosis type i","volume":"132","author":"Broomfield","year":"2021","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgmr.2026.101308_bb0510","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.prrv.2010.10.005","article-title":"Respiratory manifestations in mucopolysaccharidoses","volume":"12","author":"Muhlebach","year":"2011","journal-title":"Paediatr. Respir. Rev."},{"issue":"6","key":"10.1016\/j.ymgmr.2026.101308_bb0515","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/BPO.0b013e31829abfe0","article-title":"Hip dysplasia in patients with hurler syndrome (mucopolysaccharidosis type 1H)","volume":"33","author":"Thawrani","year":"2013","journal-title":"J. Pediatr. Orthop."},{"issue":"2","key":"10.1016\/j.ymgmr.2026.101308_bb0520","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01241398-199903000-00026","article-title":"Genu valgum deformity in hurler syndrome after hematopoietic stem cell transplantation: correction by surgical intervention","volume":"19","author":"Odunusi","year":"1999","journal-title":"J. Pediatr. Orthop."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101308_bb0525","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/BPO.0000000000000385","article-title":"A long-term retrospective evaluation of functional and radiographic outcomes of pediatric hip surgery in hurler syndrome","volume":"36","author":"Kennedy","year":"2016","journal-title":"J. Pediatr. Orthop."},{"issue":"745","key":"10.1016\/j.ymgmr.2026.101308_bb0530","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi8214","article-title":"Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for hurler syndrome","volume":"16","author":"Consiglieri","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.ymgmr.2026.101308_bb0535","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.bmt.1705586","article-title":"Analysis of factors affecting development of carpal tunnel syndrome in patients with hurler syndrome after hematopoietic cell transplantation","volume":"39","author":"Khanna","year":"2007","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"10.1016\/j.ymgmr.2026.101308_bb0540","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.eprac.2024.03.004","article-title":"A comprehensive review of empty Sella and empty Sella syndrome","volume":"30","author":"Lundholm","year":"2024","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.ymgmr.2026.101308_bb0545","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.925378","article-title":"A multicenter cohort study in patients with primary empty Sella: hormonal and neuroradiological features over a long follow-up","volume":"13","author":"Carosi","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ymgmr.2026.101308_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.tria.2025.100415","article-title":"Cadaveric case analysis of primary empty Sella with clinical literature review of empty Sella syndrome","volume":"40","author":"Hensley","year":"2025","journal-title":"Transl. Res. Anatomy"},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101308_bb0555","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.CC.N.00132","article-title":"Long-term results of carpal tunnel and trigger finger releases in a patient with hurler syndrome","volume":"5","author":"Wyffels","year":"2015","journal-title":"JBJS Case Connect."},{"key":"10.1016\/j.ymgmr.2026.101308_bb0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5348\/100074Z10AR2020CR","article-title":"Hurler syndrome and breast cancer with metastasis: a case report","volume":"6","author":"Regalbuto","year":"2020","journal-title":"J. Case Reports Images Oncol."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426926000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426926000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:17:37Z","timestamp":1784906257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426926000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":112,"alternative-id":["S2214426926000200"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2026.101308","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adult disease burden in patients with mucopolysaccharidosis type I H (Hurler syndrome): A comprehensive literature review with patient case analysis","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2026.101308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101308"}}